当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析 - 现金流量表

盟科药业-U

(688373)

  

流通市值:30.40亿  总市值:32.94亿
流通股本:6.06亿   总股本:6.56亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金50,876,476.65154,244,657.8110,478,494.5571,051,858.18
  收到其他与经营活动有关的现金11,434,630.588,394,563.947,228,482.73,144,631.54
  经营活动现金流入小计62,311,107.23162,639,221.74117,706,977.2574,196,489.72
  购买商品、接受劳务支付的现金55,252,767.83246,327,825.83182,874,873.43121,952,806.86
  支付给职工以及为职工支付的现金21,183,794.13103,141,966.3179,617,413.4854,785,443.06
  支付的各项税费1,130,337.9712,223,397.8510,972,264.6510,458,533.09
  支付其他与经营活动有关的现金757,692.3311,124,173.159,870,452.557,704,385.49
  经营活动现金流出小计78,324,592.26372,817,363.14283,335,004.11194,901,168.5
  经营活动产生的现金流量净额-16,013,485.03-210,178,141.4-165,628,026.86-120,704,678.78
二、投资活动产生的现金流量:
  收回投资收到的现金687,190,055.612,662,132,824.031,925,256,071.611,392,059,812.89
  取得投资收益收到的现金1,327,289.046,780,551.715,350,663.783,719,749.16
  处置固定资产、无形资产和其他长期资产收回的现金净额-3,789.513,789.51-
  投资活动现金流入小计688,517,344.652,668,917,165.251,930,610,524.91,395,779,562.05
  购建固定资产、无形资产和其他长期资产支付的现金24,863.2549,086.98631,741.98259,932.35
  投资支付的现金666,090,894.812,502,876,863.491,753,093,752.881,357,980,818.93
  投资活动现金流出小计666,115,758.012,503,425,950.471,753,725,494.861,358,240,751.28
  投资活动产生的现金流量净额22,401,586.64165,491,214.78176,885,030.0437,538,810.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金-3,114,445--
  取得借款收到的现金-205,702,238.6991,702,238.6971,702,238.69
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-208,816,683.6991,702,238.6971,702,238.69
  偿还债务支付的现金10,313,974.55116,455,111.9619,743,974.5512,010,000
  分配股利、利润或偿付利息支付的现金3,341,493.238,875,080.256,517,474.14,303,012.1
  支付其他与筹资活动有关的现金202,797.7315,175,944.6111,389,209.97,716,039.18
  筹资活动现金流出小计13,858,265.51140,506,136.8237,650,658.5524,029,051.28
  筹资活动产生的现金流量净额-13,858,265.5168,310,546.8754,051,580.1447,673,187.41
四、汇率变动对现金及现金等价物的影响-347,221.67-2,020,749.46-1,608,325.68-934,222.35
五、现金及现金等价物净增加额-7,817,385.5721,602,870.7963,700,257.64-36,426,902.95
  加:期初现金及现金等价物余额294,935,161.41273,332,290.62273,332,290.62273,332,290.62
  期末现金及现金等价物余额287,117,775.84294,935,161.41337,032,548.26236,905,387.67
补充资料:
  净利润--241,612,359.49--138,674,492.55
  固定资产和投资性房地产折旧-2,337,672.61-1,154,661.21
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-2,337,672.61-1,154,661.21
  无形资产摊销-733,087.06-439,071.2
  长期待摊费用摊销-3,056,906.28-1,528,453.14
  处置固定资产、无形资产和其他长期资产的损失--1,496.97--
  固定资产报废损失----4,427.63
  公允价值变动损失--6,490,192.45--4,261,022.11
  财务费用-12,686,689.18-4,813,649.95
  存货的减少-2,683,587.83-2,416,801.55
  经营性应收项目的减少--27,256,175.3--2,882,985.89
  经营性应付项目的增加-17,055,425.09--6,768,929.53
  不涉及现金收支的投资和筹资活动金额其他项目-325,782.09--
  现金的期末余额-294,935,161.41-236,905,387.67
  减:现金的期初余额-273,332,290.62-273,332,290.62
  现金及现金等价物的净增加额-21,602,870.79--36,426,902.95
公告日期2026-04-292026-03-282025-10-282025-08-20
审计意见(境内)标准无保留意见
TOP↑